{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74068",
      "recalling_firm": "Sandoz, Inc",
      "address_1": "506 Carnegie Ctr Ste 400",
      "address_2": "N/A",
      "postal_code": "08540-6243",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1045-2016",
      "product_description": "Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz  Inc.,  Princeton, NJ 08540, Product of Spain, NDC 0781-2248-01",
      "product_quantity": "78,606 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.",
      "recall_initiation_date": "20160502",
      "center_classification_date": "20160620",
      "termination_date": "20170817",
      "report_date": "20160629",
      "code_info": "Lot #s: EN3846, Exp 08/2016; FA4809, Exp 2/2017, FW3654 , Exp11/2017"
    }
  ]
}